Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
August 08, 2023 at 07:29 AM EDT
Obesity drug shows positive results in tackling some of the other illnesses caused by being overweight.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|